shares of verrica pharmaceuticals were down on friday after the company said the food and drug administration approved ycanth topical solution for the treatment of molluscum contagiosum in adults and patients ages two and up trading resumed at 455 pm et following a halt at 358 pm et ahead of the news the stock closed the regular trading session up 38 at 746 and has soared 171 this year through the close the dermatology therapeutics company said it plans to make ycanth available by september molluscum contagiosum is an infection caused by a poxvirus which can result in a benign mild skin disease characterized by growths on the body